Dr. David Carbone is director of the James Thoracic Center at James Cancer Hospital and Solove Research Institute at Ohio State University. He received his MD and PhD from Johns Hopkins University. Dr. Carbone completed his internal medicine residency at Johns Hopkins University and a medical oncology fellowship at the National Cancer Institute.
His clinical specialty is lung cancer, and he served on the Board of Directors of the International Association for the Study of Lung Cancer (IASLC). He also sits on the scientific advisory board at LUNGevity. Dr. Carbone’s research interests have focused on proteomic and expression array signature development in lung cancer, lung cancer genetics, cancer immunotherapy, tumor-associated immunosuppression mechanisms, and gene therapy. His most recent research has focused on molecular biomarkers and molecular profiling of lung cancers.